12/03/2024
4:15 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
1:08 PM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
11:41 AM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/04/2024
4:09 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
2:49 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/21/2024
2:53 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:35 PM | Heron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/22/2024
8:44 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:54 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:32 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:44 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
3:43 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
1:21 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:34 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
10:08 AM | Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
05/29/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
1:33 PM | Heron Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
1:36 PM | Heron Therapeutics (Filer)
| Form ARS | |
04/19/2024
4:48 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:02 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:21 PM | Heron Therapeutics (Filer)
| Form PRE 14A | |
04/19/2024
3:34 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:32 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:46 AM | Deep Track Capital, LP (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
10:43 AM | FRANKLIN RESOURCES INC (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
7:01 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:58 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:00 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:01 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:01 PM | Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:02 PM | Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:03 PM | Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:04 PM | Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:04 PM | Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
8:05 PM | Christian Waage (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
4:19 PM | Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:07 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
12/22/2023
3:30 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:25 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
